Vol 6, No 6 (December 04, 2017): Chinese Clinical Oncology (Pancreas Adenocarcinoma Part II Guest Editors: Eileen O’Reilly, Lei Zheng)

Preface

Preface for Special Edition Pancreas Cancer
Eileen M. O’Reilly, Lei Zheng
Chinese Clinical Oncology  
2017;
6
(6)
:57
.

Review Article

Inherited pancreatic cancer
Fei Chen, Nicholas J. Roberts, Alison P. Klein
Chinese Clinical Oncology  
2017;
6
(6)
:58
.
Pathologic classification of “pancreatic cancers”: current concepts and challenges
Mohamed E. Mostafa, Ipek Erbarut-Seven, Burcin Pehlivanoglu, Volkan Adsay
Chinese Clinical Oncology  
2017;
6
(6)
:59
.
The diagnosis and management of cystic lesions of the pancreas
Peter J. Allen
Chinese Clinical Oncology  
2017;
6
(6)
:60
.
Risk factors, biomarker and imaging techniques used for pancreatic cancer screening
Cyrus Thomas
Chinese Clinical Oncology  
2017;
6
(6)
:61
.
Imaging for pancreatic ductal adenocarcinoma
Natally Horvat, Davinia E. Ryan, Maria D. LaGratta, Pari M. Shah, Richard Kinh Do
Chinese Clinical Oncology  
2017;
6
(6)
:62
.
Interventional endoscopy in the diagnosis and management of pancreatic adenocarcinoma
Asim S. Khokhar, Amna F. Sher, Mark Schattner
Chinese Clinical Oncology  
2017;
6
(6)
:63
.
Technical aspects of pancreaticoduodenectomy and their outcomes
Katherine Giuliano, Aslam Ejaz, Jin He
Chinese Clinical Oncology  
2017;
6
(6)
:64
.
Targeting the stroma in pancreatic cancer
Daniel H. Ahn, Ramesh K. Ramanathan
Chinese Clinical Oncology  
2017;
6
(6)
:65
.
Chimeric antigen receptor (CAR) T and other T cell strategies for pancreas adenocarcinoma
Anna M. Varghese
Chinese Clinical Oncology  
2017;
6
(6)
:66
.

Perspective

Advocacy and pancreas cancer: a new world
Jane Mahoney Holt, Matthew R. Alsante
Chinese Clinical Oncology  
2017;
6
(6)
:67
.

Disclosure:

The focused issue “Pancreas Adenocarcinoma Part II” was commissioned by the Editorial office, Chinese Clinical Oncology without any sponsorship or funding. Eileen M. O’Reilly and Lei Zheng served as the unpaid Guest Editors for the focused issue.